Learning Objectives
Upon completion of this activity, participants should be able to:
Review recent data on the use of protease inhibitors and entry inhibitors in multiclass-experienced patients.
Discuss the goals of therapy in multiclass-experienced patients, and the consequences of incomplete virologic suppression.
Discuss clinical strategies designed to maximize the likelihood of achieving virologic suppression in multiclass-experienced patients.
CCO Webcasts combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.